Transperitoneal Laparoscopic Radical Nephrectomy for Patients With Dialysis-dependent End-stage Renal Disease

An Analysis and Comparison of Perioperative Outcome

Vincent G. Bird, John M. Shields, Mohammed Aziz, Rosely De Los Santos, Rajnikanth Ayyathurai, Gaetano Ciancio

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objectives: To evaluate LRN as treatment for high risk patients. Laparoscopic radical nephrectomy (LRN) is performed for renal tumors not amenable to nephron-sparing treatments. Indications are increasing to include higher risk patients including those with end-stage renal disease (ESRD) necessitating dialysis. Methods: We performed a retrospective analysis of a patient cohort with clinical stage T1 renal tumors undergoing transperitoneal LRN. Parameters examined included patient demographics, medical comorbidities, tumor characteristics, operative outcomes, and complications. Results: One hundred eighty-nine patients underwent 195 LRN. Sixteen patients (8.5%) had preexistent ESRD requiring dialysis. A higher American Society of Anesthiologists score (P <.05), higher age-adjusted Charlson comorbidity index (P = .003), higher incidence of previous abdominal surgery (P = .012), and higher incidence of hypertension (P = .025) were found for the ESRD group. Mean blood loss was 153.0 and 132.0 mL (P = .71) in the ESRD patients and non-ESRD patients, respectively. A longer stay (P = .02) was noted for ESRD patients. Mean tumor size in the ESRD patients and non-ESRD patients was 2.6 and 4.2 cm (P <.05), respectively. Renal cell carcinoma was the most common pathology in 14 of 20 (70.0%) ESRD patient renal units and 167 of 175 (95.4%) non-ESRD patient renal units (P = .001). Intraoperative and postoperative complication rates were 6.3% and 31.3% respectively for ESRD patients (P = .05), and 8.7% and 21.4% respectively for non-ESRD patients (P = .35). Most postoperative complications were minor. Conclusions: LRN, for the treatment of renal tumors in ESRD patients requiring dialysis, is feasible and safe with acceptable intraoperative and postoperative complication rates. Patients with ESRD may require longer hospital stay after LRN.

Original languageEnglish
Pages (from-to)1335-1342
Number of pages8
JournalUrology
Volume75
Issue number6
DOIs
StatePublished - Jun 1 2010

Fingerprint

Nephrectomy
Chronic Kidney Failure
Dialysis
Kidney
Intraoperative Complications
Neoplasms
Comorbidity
Incidence
Nephrons
Renal Cell Carcinoma

ASJC Scopus subject areas

  • Urology

Cite this

Transperitoneal Laparoscopic Radical Nephrectomy for Patients With Dialysis-dependent End-stage Renal Disease : An Analysis and Comparison of Perioperative Outcome. / Bird, Vincent G.; Shields, John M.; Aziz, Mohammed; De Los Santos, Rosely; Ayyathurai, Rajnikanth; Ciancio, Gaetano.

In: Urology, Vol. 75, No. 6, 01.06.2010, p. 1335-1342.

Research output: Contribution to journalArticle

Bird, Vincent G. ; Shields, John M. ; Aziz, Mohammed ; De Los Santos, Rosely ; Ayyathurai, Rajnikanth ; Ciancio, Gaetano. / Transperitoneal Laparoscopic Radical Nephrectomy for Patients With Dialysis-dependent End-stage Renal Disease : An Analysis and Comparison of Perioperative Outcome. In: Urology. 2010 ; Vol. 75, No. 6. pp. 1335-1342.
@article{d44393025db6406ebb4eb267b66a966e,
title = "Transperitoneal Laparoscopic Radical Nephrectomy for Patients With Dialysis-dependent End-stage Renal Disease: An Analysis and Comparison of Perioperative Outcome",
abstract = "Objectives: To evaluate LRN as treatment for high risk patients. Laparoscopic radical nephrectomy (LRN) is performed for renal tumors not amenable to nephron-sparing treatments. Indications are increasing to include higher risk patients including those with end-stage renal disease (ESRD) necessitating dialysis. Methods: We performed a retrospective analysis of a patient cohort with clinical stage T1 renal tumors undergoing transperitoneal LRN. Parameters examined included patient demographics, medical comorbidities, tumor characteristics, operative outcomes, and complications. Results: One hundred eighty-nine patients underwent 195 LRN. Sixteen patients (8.5{\%}) had preexistent ESRD requiring dialysis. A higher American Society of Anesthiologists score (P <.05), higher age-adjusted Charlson comorbidity index (P = .003), higher incidence of previous abdominal surgery (P = .012), and higher incidence of hypertension (P = .025) were found for the ESRD group. Mean blood loss was 153.0 and 132.0 mL (P = .71) in the ESRD patients and non-ESRD patients, respectively. A longer stay (P = .02) was noted for ESRD patients. Mean tumor size in the ESRD patients and non-ESRD patients was 2.6 and 4.2 cm (P <.05), respectively. Renal cell carcinoma was the most common pathology in 14 of 20 (70.0{\%}) ESRD patient renal units and 167 of 175 (95.4{\%}) non-ESRD patient renal units (P = .001). Intraoperative and postoperative complication rates were 6.3{\%} and 31.3{\%} respectively for ESRD patients (P = .05), and 8.7{\%} and 21.4{\%} respectively for non-ESRD patients (P = .35). Most postoperative complications were minor. Conclusions: LRN, for the treatment of renal tumors in ESRD patients requiring dialysis, is feasible and safe with acceptable intraoperative and postoperative complication rates. Patients with ESRD may require longer hospital stay after LRN.",
author = "Bird, {Vincent G.} and Shields, {John M.} and Mohammed Aziz and {De Los Santos}, Rosely and Rajnikanth Ayyathurai and Gaetano Ciancio",
year = "2010",
month = "6",
day = "1",
doi = "10.1016/j.urology.2009.10.030",
language = "English",
volume = "75",
pages = "1335--1342",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Transperitoneal Laparoscopic Radical Nephrectomy for Patients With Dialysis-dependent End-stage Renal Disease

T2 - An Analysis and Comparison of Perioperative Outcome

AU - Bird, Vincent G.

AU - Shields, John M.

AU - Aziz, Mohammed

AU - De Los Santos, Rosely

AU - Ayyathurai, Rajnikanth

AU - Ciancio, Gaetano

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Objectives: To evaluate LRN as treatment for high risk patients. Laparoscopic radical nephrectomy (LRN) is performed for renal tumors not amenable to nephron-sparing treatments. Indications are increasing to include higher risk patients including those with end-stage renal disease (ESRD) necessitating dialysis. Methods: We performed a retrospective analysis of a patient cohort with clinical stage T1 renal tumors undergoing transperitoneal LRN. Parameters examined included patient demographics, medical comorbidities, tumor characteristics, operative outcomes, and complications. Results: One hundred eighty-nine patients underwent 195 LRN. Sixteen patients (8.5%) had preexistent ESRD requiring dialysis. A higher American Society of Anesthiologists score (P <.05), higher age-adjusted Charlson comorbidity index (P = .003), higher incidence of previous abdominal surgery (P = .012), and higher incidence of hypertension (P = .025) were found for the ESRD group. Mean blood loss was 153.0 and 132.0 mL (P = .71) in the ESRD patients and non-ESRD patients, respectively. A longer stay (P = .02) was noted for ESRD patients. Mean tumor size in the ESRD patients and non-ESRD patients was 2.6 and 4.2 cm (P <.05), respectively. Renal cell carcinoma was the most common pathology in 14 of 20 (70.0%) ESRD patient renal units and 167 of 175 (95.4%) non-ESRD patient renal units (P = .001). Intraoperative and postoperative complication rates were 6.3% and 31.3% respectively for ESRD patients (P = .05), and 8.7% and 21.4% respectively for non-ESRD patients (P = .35). Most postoperative complications were minor. Conclusions: LRN, for the treatment of renal tumors in ESRD patients requiring dialysis, is feasible and safe with acceptable intraoperative and postoperative complication rates. Patients with ESRD may require longer hospital stay after LRN.

AB - Objectives: To evaluate LRN as treatment for high risk patients. Laparoscopic radical nephrectomy (LRN) is performed for renal tumors not amenable to nephron-sparing treatments. Indications are increasing to include higher risk patients including those with end-stage renal disease (ESRD) necessitating dialysis. Methods: We performed a retrospective analysis of a patient cohort with clinical stage T1 renal tumors undergoing transperitoneal LRN. Parameters examined included patient demographics, medical comorbidities, tumor characteristics, operative outcomes, and complications. Results: One hundred eighty-nine patients underwent 195 LRN. Sixteen patients (8.5%) had preexistent ESRD requiring dialysis. A higher American Society of Anesthiologists score (P <.05), higher age-adjusted Charlson comorbidity index (P = .003), higher incidence of previous abdominal surgery (P = .012), and higher incidence of hypertension (P = .025) were found for the ESRD group. Mean blood loss was 153.0 and 132.0 mL (P = .71) in the ESRD patients and non-ESRD patients, respectively. A longer stay (P = .02) was noted for ESRD patients. Mean tumor size in the ESRD patients and non-ESRD patients was 2.6 and 4.2 cm (P <.05), respectively. Renal cell carcinoma was the most common pathology in 14 of 20 (70.0%) ESRD patient renal units and 167 of 175 (95.4%) non-ESRD patient renal units (P = .001). Intraoperative and postoperative complication rates were 6.3% and 31.3% respectively for ESRD patients (P = .05), and 8.7% and 21.4% respectively for non-ESRD patients (P = .35). Most postoperative complications were minor. Conclusions: LRN, for the treatment of renal tumors in ESRD patients requiring dialysis, is feasible and safe with acceptable intraoperative and postoperative complication rates. Patients with ESRD may require longer hospital stay after LRN.

UR - http://www.scopus.com/inward/record.url?scp=77952744721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952744721&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2009.10.030

DO - 10.1016/j.urology.2009.10.030

M3 - Article

VL - 75

SP - 1335

EP - 1342

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6

ER -